In a 1992 study in rats, the major finding was that intraperitoneal DSIP injection increased the concentration of substance P a neurotransmitter positively correlated with the regulation of anxiety and mood15 in the hypothalamus, suggesting to the researchers that the peptide sharply decreases the classical manifestations of stress.16 Earlier studies in humans, namely a series of five trials published in 1983, came to similar conclusions, with better relaxation and apparently improved tolerance against psychic stress reported by the subjects.17 Its possible that the improved stress and anxiety markers were consequent to DSIP-associated sleep enhancements.18 Substance use recovery A study from 1984 published in European Neurology describes DSIPs potential use as a treatment for alcohol and opiate use disorders
Researchers studying gastrointestinal effects have used both acute (single-dose) and chronic (7-14 day) protocols, with efficacy observed in both paradigms
(PubMed) Ipamorelin is a growth hormone secretagogue (ghrelin receptor agonist class) designed to stimulate GH release with relative selectivity (less spillover into some other pituitary hormones compared with earlier compounds, based on early pharmacology literature)
Several Lactobacillus species require nicotinamide or nicotinic acid for growth 94
Peptides work best as part of a comprehensive recovery strategy
It is being actively studied in metabolic research for its ability to enhance insulin secretion , reduce appetite , improve insulin sensitivity , and support weight loss through central and peripheral mechanisms